lncRNA LUCAT1 调节质瘤干细胞在低氧条件下的DNA损伤反应
Haidong Huang1, Hariti Shah1, Himanshu Dashora1
1Department of Cancer Sciences, Cleveland Clinic, 9500 Euclid Avenue, NE60, Cleveland, OH, 44195, USA.
Neuro-oncology
|January 31, 2026
概括
长非编码RNA LUCAT1 在低氧条件下调节质母细胞干细胞中的DNA修复. 抑制 LUCAT1 增强了 DNA 损伤,并提高了 GBM 放射治疗的有效性.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 基因组学就是基因组学.
背景情况:
- 基因组稳定性对于细胞生存至关重要,特别是在缺氧压力下损害DNA修复的条件下.
- 质母细胞瘤 (GBM) 对破坏DNA的疗法具有抗性,这种抗性归因于质母细胞 (GSC) 和缺氧瘤微环境.
- 长非编码RNAs (lncRNAs) 与基因组完整性有关,但它们在缺氧GSC中的DNA损伤反应 (DDR) 中的作用尚不清楚.
研究的目的:
- 研究LUCAT1的作用,一个缺氧诱导的lncRNA,在调节DNA损伤反应 (DDR) 在质母细胞干细胞 (GSCs).
- 阐明 LUCAT1 影响 DNA 修复通路的分子机制.
- 评估向LUCAT1的治疗潜力,以提高GBM治疗疗效.
主要方法:
- 使用iDRIP和质谱学识别低毒GSC中的LUCAT1相互作用蛋白.
- 通过RNA拉低和RNA免疫沉降试验确认相互作用.
- 机理学研究包括免疫沉,近距离结合试验,彗星试验,免疫覆盖和通过shRNA敲击LUCAT1;利用RNAseq和TCGA数据集进行基因表达分析;在GSC和正位异种移植中进行功能试验.
主要成果:
- LUCAT1直接与DNA-PK全酶相互作用,调节非同源端结合 (NHEJ) 途径.
- LUCAT1调节BRCA1和RAD51,是同源重组 (HR) 途径的关键组成部分.
- 在接受放射治疗的小鼠中,LUCAT1的枯竭导致DNA损伤增加,GSC对DDR抑制剂的敏感性增加,并改善了生存率.
结论:
- 在低氧条件下,LUCAT1被确定为GSC中DNA损伤反应的关键调节者.
- 向LUCAT1是一个有希望的策略,可以提高DNA损伤反应抑制剂和放射治疗在质母细胞瘤治疗中的疗效.
相关概念视频
lncRNA - Long Non-coding RNAs
10.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
DNA Damage Can Stall the Cell Cycle
3.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.1K
DNA Damage can Stall the Cell Cycle
10.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.1K
Regulation of Hematopoietic Stem Cells
4.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Regulation of the Unfolded Protein Response
3.0K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.0K
Covalently Linked Protein Regulators
9.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.6K


